Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia

NCT01361711 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Stage I Chronic Lymphocytic Leukemia
Stage II Chronic Lymphocytic Leukemia
Stage III Chronic Lymphocytic Leukemia
Stage IV Chronic Lymphocytic Leukemia

Interventions

BIOLOGICAL: alemtuzumab
BIOLOGICAL: ofatumumab
PROCEDURE: biopsy

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]